HYBRID EVENT: You can participate in person at Singapore or Virtually from your home or work.

5th Edition of

International Public Health Conference

March 19-21, 2026 | Singapore

IPHC 2026

Assessing human exposure to key chemical carcinogens diagnostic approaches and interpretation

Speaker at International Public Health Conference 2026 - Vladan Radosavljevic
Military Medical Academy, Serbia
Title : Assessing human exposure to key chemical carcinogens diagnostic approaches and interpretation

Abstract:

Chemical carcinogens classified by the International Agency for Research on Cancer (IARC) as Group 1 very probably contribute to cancer occurrence in over 13.5 million people and death from cancer in over seven million people. In percent, chemical elements and chemical compounds very probably contribute to cancer occurrence in about 68% of all cancer cases and very probably significantly contribute to cancer death in about 72% of all cancer deaths (yearly and globally). There are two main reasons for increasing cancer cases in the next decades: first, growing of the world population and, second, un-proportional growing of the elderly population. Consequently, by 2050, the number of cancer cases predicts to reach 35 million. The mentioned chemical carcinogens were used for decades without proper evaluation of their health effects. Early detection is crucial as most carcinogens have cumulative effects. Identifying urinary markers of exposure can help detect, eliminate, or reduce sources of carcinogens, advancing preventive oncology. While complete eliminating carcinogens is impossible, improving detection and monitoring―especially through specialized urine analysis―can help define preventive measures to lower carcinogen levels in the body. Described screening protocol is applicable in any location with HPLC (High Performance Liquid Chromatography) and ICP (Inductively Coupled Plasma) devices. They are non-invasive, quick, effective, affordable, and inexpensive requiring only urine samples. This screening protocol aims to develop, improve, and implement screening protocol for many malignant diseases and some chronic non-communicable diseases like cardiovascular, endocrine, neurological, hematological, dermatological, and malignant diseases. It supports medical professionals in interpreting HPLC and ICP urinary analyses and providing guidance on reducing or avoiding carcinogen exposure. In some cases, doctors may identify sources of exposure and inform authorities to address and eliminate these hazards.

Biography:

Vladan Radosavljeviс graduated from the Medical Faculty of the University of Belgrade, Serbia, in 1991. He specialized (May 1995) and received his doctorate (November 1999) in epidemiology at the Medical Faculty of the University of Belgrade. Dr. Radosavljeviс was the head of the Department of Epidemiology and deputy director of the Military Institute for Preventive Medicine in Belgrade from 2003 to 2010. He was the head of military preventive medicine from 2010 to 2020 in the Ministry of Defence of Serbia, and in 2020 he moved to the Institute of Epidemiology of the Military Medical Academy, Belgrade, where he works as an expert epidemiologist. He was a professor at the Biological Weapons course at the Military Academy of the University of Defence in Belgrade and a research associate at the Epidemiology course. Since 2015, Dr. Radosavljeviс is a United Nations expert on biological weapons within the mechanism of the United Nations Secretary General.

Watsapp